Call Us for Support
+91 9654860915
Google Reviews
4.8
Call Us for Support
+91 9654860915
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
Ready to proceed? Start a request for Sebaloxavir Marboxil on our secure patient portal to submit your prescription, upload documents and track your approval status.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
China
Regulatory Approval:
Your Trustworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Sebaloxavir marboxil is a single-dose oral antiviral for flu, developed in China by Zenshine Pharmaceuticals (征祥医药) in Nanjing and sold there as 济可舒® (Jikeshu). The whole course is one dose, taken once. In mainland China it is promoted and sold by JumpCan Pharmaceutical under an agreement with Zenshine.
China's National Medical Products Administration (NMPA) approved it for adults in July 2025 and extended it to adolescents in June 2026. It is now approved for:
It is a prescription infection medicine and should be used only on a doctor's advice.
The tablet is a "prodrug" that the body converts into its active form. This blocks the PA cap-dependent endonuclease, the part of the flu virus that cuts a cap from the patient's own genetic messages so the virus can copy itself. Without it, the virus cannot multiply. The active form lasts a long time in the body (a half-life of about 83 to 126 hours in volunteers), so one dose covers the illness. It is not broken down by the CYP liver enzymes, which lowers the chance of interactions with many everyday medicines.
In the adult phase 2/3 trial, published in Clinical Microbiology and Infection in 2025, a single 80 mg dose eased flu symptoms in a median of 39.4 hours compared with 62.9 hours on placebo. Virus RNA became undetectable in a median of about 41 hours against about 91 hours with placebo. A separate phase 3 trial in teenagers found that a 40 mg dose eased symptoms in a median of about 52 hours compared with about 82 hours on placebo.
Your doctor will confirm whether it suits you. Flu antivirals work best when started early.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Side effects: in the adult phase 3 trial, side effects of any kind were actually reported less often than with placebo (44.2% with the 80 mg dose vs 53.8% with placebo), and most were mild or moderate. Common reactions listed in the Chinese product information for adults include a drop in white blood cells called neutrophils (2.7%), a drop in total white cells (1.0%) and diarrhoea. In teenagers, the listed reactions were sinus arrhythmia (4.4%), a slow heart rate (sinus bradycardia, 3.9%) and raised uric acid (2.2%), mostly mild.
It is not approved for children under 12 or for people at high risk of flu complications. Tell your doctor about all the medicines and supplements you take.
Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.
Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.
Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.
Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.
Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.
Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.
The tablets can be imported only in the patient's name, by the patient or a government hospital, in line with India's import regulations for unapproved medicines. You will need:
Once we have received and checked a valid prescription and, where needed, an import permit.
No. It is approved only in China. It has no CDSCO approval, it is not sold in Indian pharmacies, and the US FDA and European Medicines Agency have not approved it either.
Patients can still get it legally through the Named Patient Program (NPP), which allows a medicine not registered in India to be imported for one specific patient on a prescription. Because the dose should be taken within 48 hours of the first symptoms, ask your doctor whether the import timeline still fits. For other imported antiviral tablets, see our pages on Atilotrelvir and Livtencity.
It can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.
NamedPatientProgram.com (NPP) sources this medicine through the manufacturer's authorised supply channels in China and arranges supply to patients, doctors, and hospitals under applicable legal provisions. Each box holds two 40 mg tablets, which is one adult dose; the tablets stay sealed in their original pack and are stored as directed on the pack during transit. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.
For the current cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Patients across India can access this medicine through regulated import pathways, with delivery arranged to the patient or the treating clinic on a valid doctor's prescription.
Being close to our New Delhi dispatch point gives the shortest wait, useful for a medicine meant to be taken early.
Doctors in Mumbai can send the prescription and flu test together so the document check moves quickly.
The one-box adult course can be delivered to the patient's home or clinic in Bangalore after verification.
We share the quote and expected arrival date first, so the doctor can judge whether the timing still works.
Physicians in Hyderabad can request it for a named adult or teenage patient aged 12 or over.
Deliveries to Kolkata and the eastern states are planned to arrive as fast as the import allows.
Patients in Pune can use the same documented import route, with updates at each stage.
The treating doctor can send us the prescription and supporting reports to begin the request.
Serves patients from Punjab, Haryana and Himachal Pradesh, with delivery to the patient or the treating hospital.
Patients in Rajasthan can receive the pack at home, as long as the import is in their own name.
We coordinate delivery for patients treated at public and private hospitals across Uttar Pradesh.
Families across Kerala can have the tablets delivered to their home or hospital in Kochi and nearby cities.
Access can also be coordinated for patients in other Indian cities, subject to a valid prescription and regulatory requirements.
Written By
Nitin GoswamiDeputy Manager – Content & Social Media, Ikris Pharma Network
Sources: NMPA • CDSCO
Last Updated: 19 October 2026
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message
